GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » Cash And Cash Equivalents

AOBI (American Oriental Bioengineering) Cash And Cash Equivalents : $3.2 Mil (As of Sep. 2013)


View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering Cash And Cash Equivalents?

American Oriental Bioengineering's quarterly cash and cash equivalents increased from Mar. 2013 ($6.42 Mil) to Jun. 2013 ($7.01 Mil) but then stayed the same from Jun. 2013 ($7.01 Mil) to Sep. 2013 ($3.23 Mil).

American Oriental Bioengineering's annual cash and cash equivalents declined from Dec. 2010 ($94.57 Mil) to Dec. 2011 ($52.63 Mil) and declined from Dec. 2011 ($52.63 Mil) to Dec. 2012 ($7.10 Mil).


American Oriental Bioengineering Cash And Cash Equivalents Historical Data

The historical data trend for American Oriental Bioengineering's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering Cash And Cash Equivalents Chart

American Oriental Bioengineering Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.06 91.13 94.57 52.63 7.10

American Oriental Bioengineering Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.43 7.10 6.42 7.01 3.23

American Oriental Bioengineering Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


American Oriental Bioengineering  (OTCPK:AOBI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


American Oriental Bioengineering Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oriental Bioengineering Business Description

Traded in Other Exchanges
N/A
Address
1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176
American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.
Executives
Patti Cosimo J director AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering Headlines

No Headlines